It was thought that LGI1 antibodies made exclusive contributions in the pathogenic mechanism of AE diseases, on account of the fact that these antibodies could disrupt the ligand–receptor interaction between LGI1 and ADAM22, by binding the specific epitope of LGI1 which was found to be EPTP repeat domain (54). Here, LGI1 is linked to acrodermatitis enteropathica.